Related Experiment Videos
The interaction of quinacrine with triple-stranded poly(U).poly(A).poly(U)
Nucleic Acids Symposium Series
|January 1, 1995
Summary
The antimalarial drug quinacrine (QAC) binds to triple-stranded DNA. QAC intercalates into U.A.U base triplets from the minor groove, revealing a novel drug-DNA interaction mechanism.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- The antimalarial drug quinacrine (QAC) is known to interact with nucleic acids.
- Understanding drug-nucleic acid interactions is crucial for drug development and understanding drug mechanisms.
- Triple-stranded nucleic acid structures offer unique binding sites for small molecules.
Purpose of the Study:
- To investigate the interaction between quinacrine (QAC) and triple-stranded poly(U).poly(A).poly(U) (poly(U.A.U)).
- To elucidate the binding mode and specificity of QAC with different nucleic acid structures.
- To explore the potential of QAC as a ligand for triple-stranded DNA.
Main Methods:
- Absorption spectroscopy
- Fluorescence spectroscopy
- Circular dichroism (CD) measurements
Main Results:
- Quinacrine (QAC) was found to bind to triple-stranded poly(U.A.U).
- QAC also binds to double-stranded poly(A).poly(U) (poly(A.U)) and poly(I).poly(C) (poly(I.C)).
- The acridine ring of QAC intercalates into successive U.A.U base-triplets from the minor groove.
Conclusions:
- The binding of QAC to poly(U.A.U) occurs via intercalation into the minor groove.
- The presence of the third-strand poly(U) in the major groove of poly(A.U) inhibits QAC binding to the major groove.
- These findings provide insights into the molecular interactions of quinacrine with specific nucleic acid architectures.